Wells Fargo’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,463
Closed -$20K 7693
2022
Q1
$20K Buy
16,463
+7,001
+74% +$8.51K ﹤0.01% 5679
2021
Q4
$11K Sell
9,462
-206
-2% -$239 ﹤0.01% 5988
2021
Q3
$18K Buy
9,668
+136
+1% +$253 ﹤0.01% 5692
2021
Q2
$22K Buy
9,532
+2
+0% +$5 ﹤0.01% 5538
2021
Q1
$26K Buy
9,530
+3
+0% +$8 ﹤0.01% 5724
2020
Q4
$23K Buy
9,527
+8
+0.1% +$19 ﹤0.01% 5597
2020
Q3
$22K Sell
9,519
-781
-8% -$1.81K ﹤0.01% 5448
2020
Q2
$23K Sell
10,300
-7,214
-41% -$16.1K ﹤0.01% 5374
2020
Q1
$30K Sell
17,514
-3,367
-16% -$5.77K ﹤0.01% 5254
2019
Q4
$43K Sell
20,881
-15,250
-42% -$31.4K ﹤0.01% 5293
2019
Q3
$105K Buy
36,131
+2,500
+7% +$7.27K ﹤0.01% 5073
2019
Q2
$132K Buy
33,631
+32,500
+2,874% +$128K ﹤0.01% 4971
2019
Q1
$5K Sell
1,131
-125
-10% -$553 ﹤0.01% 5624
2018
Q4
$3K Buy
1,256
+165
+15% +$394 ﹤0.01% 5726
2018
Q3
$6K Sell
1,091
-125
-10% -$687 ﹤0.01% 5690
2018
Q2
$8K Sell
1,216
-1,618
-57% -$10.6K ﹤0.01% 5655
2018
Q1
$24K Buy
2,834
+1,062
+60% +$8.99K ﹤0.01% 5437
2017
Q4
$17K Sell
1,772
-290
-14% -$2.78K ﹤0.01% 5465
2017
Q3
$24K Buy
2,062
+1,562
+312% +$18.2K ﹤0.01% 5355
2017
Q2
$21K Buy
500
+375
+300% +$15.8K ﹤0.01% 5309
2017
Q1
$6K Hold
125
﹤0.01% 5584
2016
Q4
$4K Hold
125
﹤0.01% 5634
2016
Q3
$5K Hold
125
﹤0.01% 5589
2016
Q2
$4K Sell
125
-1,264
-91% -$40.4K ﹤0.01% 5562
2016
Q1
$87K Buy
1,389
+138
+11% +$8.64K ﹤0.01% 4760
2015
Q4
$52K Hold
1,251
﹤0.01% 5059
2015
Q3
$69K Buy
1,251
+885
+242% +$48.8K ﹤0.01% 4931
2015
Q2
$40K Buy
366
+213
+139% +$23.3K ﹤0.01% 5193
2015
Q1
$15K Buy
153
+5
+3% +$490 ﹤0.01% 5287
2014
Q4
$8K Hold
148
﹤0.01% 5496
2014
Q3
$11K Sell
148
-987
-87% -$73.4K ﹤0.01% 5376
2014
Q2
$170K Buy
+1,135
New +$170K ﹤0.01% 4355